Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients

American Journal of Nephrology

Volumn 26, Issue 5, 2006, Pages 497-502

  Pawlak, Krystyna ^a,b   Pawlak, Dariusz ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Nephrology and Clinical Transplantation ^*  (Poland)

Author keywords

CC chemokines; Hemodialysis; Intima media thickness; Recombinant human erythropoietin

Indexed keywords

BETA CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN; RANTES; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; INTIMA; IRON THERAPY; LABORATORY TEST; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ATHEROSCLEROSIS; CAROTID ARTERIES; CHEMOKINES, CC; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TUNICA INTIMA; TUNICA MEDIA; UREMIA;

EID: 33845790570     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097269     Document Type: Article

References (15)

1. Reape TJ, Groot PHE: Chemokines and atherosclerosis. Atherosclerosis 1999;147:213-225.
2. Rollins BJ: Chemokines. Blood 1997;90:909-928.
3. Peters W, Charo IF: Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol 2001;12:175-180.
4. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ: Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1994;1:S3-S10.
5. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990;300:573-578.
6. Sundal E, Businger J, Kappeler A: Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. Nephrol Dial Transplant 1991;6:955-965.
7. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-590.
8. Pawlak K, Pawlak D, Mysliwiec M: Oxidative stress influence CC-chemokines levels in hemodialyzed patients. Nephron Physiol 2004;96:105-112.
9. Pawlak K, Naumnik B, Brzósko S, Pawlak D, Myśliwiec M: Oxidative stress-a link between endothelial injury, coagulation activation and atherosclerosis in haemodialysis patients. Am J Nephrol 2004;24:154-161.
10. de Marchi S, Cecchin E, Falleti E, Giacomello R, Stel G, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E: Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients. J Am Soc Nephrol 1997;8:1147-1156.
11. Aguilera A, Selgas R: Effect of recombinant erythropoietin on inflammatory status in dialysis patients. Nephrol Dial Transplant 2004;19(suppl 5):v46-v53.
12. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N, Akimitsu N, Sekimizu K, Monden M, Miyasaka M: A high endothelial venule-expressing promiscuous chemokines receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003;15:1219-1227.
13. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E: Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107:690-695.
14. Pattison JM, Nelson PJ, Huide P, Sibley RK, Krensky AM: RANTES chemokines expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 1996;15:1194-1199.
15. Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, Roach AG, Westwick J, Williams RJ: Human vascular smooth muscle cells express receptors for CC-chemokines. Arterioscler Thromb Vasc Biol 1998;18:397-403.